Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction
about
The Role of Oxygen Sensors, Hydroxylases, and HIF in Cardiac Function and DiseaseStimulating endogenous cardiac repairImaging: guiding the clinical translation of cardiac stem cell therapyNovel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinomaMyocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityNanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles.Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA.Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial InfarctionShort Hairpin RNA Silencing of PHD-2 Improves Neovascularization and Functional Outcomes in Diabetic Wounds and Ischemic LimbsEssential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epitheliumNon-viral therapeutic approaches to ocular diseases: An overview and future directionsStem cell recruitment after injury: lessons for regenerative medicine.Adipose-Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA-31.Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer.Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signalingProlyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardiumAdvances in Non-Viral DNA Vectors for Gene Therapy.Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.Angiogenesis in the infarcted myocardium.Genetic modification of hypoxia signaling in animal models and its effect on cancer.Minicircle DNA vectors for gene therapy: advances and applications.Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy.Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repairCardiac gene therapy: are we there yet?NEU3 sialidase is activated under hypoxia and protects skeletal muscle cells from apoptosis through the activation of the epidermal growth factor receptor signaling pathway and the hypoxia-inducible factor (HIF)-1αExpression of short hairpin RNAs using the compact architecture of retroviral microRNA genes.Priming of the Cells: Hypoxic Preconditioning for Stem Cell TherapyHypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis.Cortical bone-derived stem cells: a novel class of cells for myocardial protection.Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells.Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.Overexpressing microRNA-150 attenuates hypoxia-induced human cardiomyocyte cell apoptosis by targeting glucose-regulated protein-94.HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia
P2860
Q26780548-3E18E7C5-4733-45CF-8F57-8D5F0C609B70Q26781323-880AEBE4-2CD2-4E88-A49A-8D17C0922CA8Q27008410-AEEB51CD-7C59-48D5-8320-4B0BCD11BC7AQ30360377-5038D569-9CD0-4045-A133-B8B32E7FB78FQ30440788-B76EF93A-D5C6-4F43-BE9F-F4D156C1AEF4Q30601810-EB1818EC-92A7-4203-BC27-B95BF9BF44CDQ34001530-CF8C73DF-822A-48FF-A7DF-C831D9076AABQ34245510-E39F0F30-78A9-4FFC-8173-9B190D2F298EQ34803426-9E3E0D0E-6F48-42A0-B542-2464EFA8100EQ35754348-A1787032-FBB9-49E7-82D7-5B2BBDF1E883Q35954187-05F42D0A-6FFD-421E-8B26-BA92ABDAB1CAQ36089079-7006530C-DE89-4CD5-825C-CFDF50D068A0Q36425890-12386404-9886-42C0-9B21-99E7ACEEF052Q36599286-B78DA9C0-F06B-4699-BE6C-BDF593C88E4DQ36703025-31377FA2-980D-4C51-A485-30314AFBE107Q36888926-C2C9539C-CE59-4775-80D6-F2500ED4D0B1Q36962758-050705C0-3CC1-4DB2-B816-88BFB4D5D7B3Q37097008-A2F1D82D-6CB9-4A78-A8FC-B0E3652D1598Q37676243-D2AC150B-6D1B-4BED-8772-8C81DA55CC37Q37997987-B2E21A7B-62D6-44DF-9BF8-207790836548Q38032602-9755AE4E-8E8D-4363-828D-4FA4DE1646A3Q38263349-02B8980B-501F-4498-90C4-210A5A9FB789Q38300052-A40497AB-82AF-4050-97AC-FD2EF282AC4CQ38577907-443DEA8A-FC5A-49A2-B0FC-8ECB91D58C6DQ38760612-68AD7DBB-8C40-4191-9611-5C0C02556D16Q38820937-43A5E310-F82D-40B9-9B00-426028ED96DDQ39233050-75D4F7BE-4011-49A3-B25B-0000C44DBE9BQ41826408-8D063F4C-9124-4880-95BA-4159425D51E3Q42267329-5C01017F-2553-43A1-9479-65C3E575B463Q42368086-88D898C7-6D8C-432F-9AAB-499DD18B0E75Q42836395-1DC20348-F428-40F3-B023-4A4EEF18993AQ46984458-8AB8D136-FA19-44E0-94FF-7CBDE6AE7336Q47648689-B013DED7-A341-493D-AFF0-C6465C528C39Q50068138-CA5BD0F7-A09F-4F06-9471-E68935CB551AQ57767255-9A932D0A-765B-43FB-9E39-F3178FD58FA9
P2860
Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Double knockdown of prolyl hyd ...... is after myocardial infarction
@ast
Double knockdown of prolyl hyd ...... is after myocardial infarction
@en
Double knockdown of prolyl hyd ...... is after myocardial infarction
@nl
type
label
Double knockdown of prolyl hyd ...... is after myocardial infarction
@ast
Double knockdown of prolyl hyd ...... is after myocardial infarction
@en
Double knockdown of prolyl hyd ...... is after myocardial infarction
@nl
prefLabel
Double knockdown of prolyl hyd ...... is after myocardial infarction
@ast
Double knockdown of prolyl hyd ...... is after myocardial infarction
@en
Double knockdown of prolyl hyd ...... is after myocardial infarction
@nl
P2093
P2860
P921
P1433
P1476
Double knockdown of prolyl hyd ...... is after myocardial infarction
@en
P2093
Amato J Giaccia
Fangjun Jia
Mark A Kay
Patricia E de Almeida
Patricia Nguyen
Yongquan Gong
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.014019
P407
P433
P577
2011-09-01T00:00:00Z